Nevro

Nevro is a medical device company based in Redwood City, California, dedicated to providing advanced treatments for chronic pain relief. Founded in 2006, Nevro focuses on innovative neuromodulation technologies to help patients achieve lasting relief from chronic pain. The company's flagship product is the Nevro® Senza® Spinal Cord Stimulation (SCS) System, which utilizes 10 kHz Therapy (HFX Therapy). This next-generation approach offers significant pain relief without the tingling sensation often associated with traditional therapies. The Senza SCS System is the most studied in the market and is approved for a variety of stimulation frequencies and waveform types, allowing for tailored treatment options. It has received CE mark approval in 2010 and FDA approval in 2015, and is available in the United States, Europe, and Australia. Nevro's services primarily target chronic pain management, including conditions like back and leg pain and painful diabetic neuropathy. The company collaborates with healthcare providers, pain specialists, and hospitals to deliver customized pain relief therapies, emphasizing innovation and patient care in the field of neuromodulation.

• Employees 1100
• Founded 2006
• Annual Revenue $408518000
• Total Funding $605604692